-
Abelaridder B, 2015: Rabies: 100 per cent fatal, 100 per cent preventable[J]. Vet Rec, 177, 148-149. doi: 10.1136/vr.h4196
-
Acharya AS, Kaur R, Lakra K, 2012: Rabies epidemiology and control in India: a review[J]. J Commun Dis, 44, 59-69.
-
Adedeji AO, Okonko IO, Eyarefe OD, Adedeji OB, Babalola ET, Ojezele MO, Nwanze JC, Amusan TA, 2010: An overview of rabies—history, epidemiology, control and possible elimination[J]. Afr J Microbiol Res, 4, 2327-2338.
-
Adolfsson J, Borge JO, Bryder D, TheilgaardMönch K, ÅstrandGrundström I, 2001: Upregulation of Flt3 expression within the bone marrow Lin-Sca1+c-kit+stem cell compartment is accompanied by loss of self-renewal capacity[J]. Immunity, 15, 659-669. doi: 10.1016/S1074-7613(01)00220-5
-
Alizadeh L, Dana MA, Dowom PB, Ghaemi A, 2015: Immunology of rabies virus in the central nervous system[J]. Osong Public Health Res Perspect, 3, 113-120.
-
Anandasabapathy N, Feder R, Mollah S, Tse SW, Longhi MP, Mehandru S, Matos I, Cheong C, Ruane D, Brane L, 2014: Classical Flt3L-dependent dendritic cells control immunity to protein vaccine[J]. J Exp Med, 211, 1875-1891. doi: 10.1084/jem.20131397
-
Ayres JA, Barraviera B, Calvi SA, Carvalho NR, Peraçoli MTS, 2006: Antibody and cytokine serum levels in patients subjected to anti-rabies prophylaxis with serum-vaccination[J]. J Venom Anim Toxins Incl Trop Dis, 12, 435-455.
-
Chen T, Zhang Y, Wang Z, Yang J, Li M, Wang K, Cui M, Fu ZF, Zhao L, Zhou M, 2017: Recombinant rabies virus expressing IL-15 enhances immunogenicity through promoting the activation of dendritic cells in mice[J]. Virol Sin, 32, 317-327. doi: 10.1007/s12250-017-4036-1
-
Conzelmann KK, Cox JH, Schneider LG, Thiel HJ, 1990: Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19[J]. Virology, 175, 485-499. doi: 10.1016/0042-6822(90)90433-R
-
Dodet B, 2010: Report of the sixth AREB meeting, Manila, The Philippines, 10-12 November 2009[J]. Vaccine, 28, 3265-3268. doi: 10.1016/j.vaccine.2010.02.093
-
Dupont CD, Pritchard GH, Hidano S, Christian DA, Wagage S, Muallem G, Wojno EDT, Hunter CA, 2015: Flt3L is essential for survival and protective immune responses during toxoplasmosis[J]. J Immunol, 195, 4369-4377. doi: 10.4049/jimmunol.1500690
-
Gao FS, Zhan YT, Wang XD, Zhang C, 2018: Enhancement of anti-tumor effect of plasmid DNA-carrying MUC1 by the adjuvanticity of FLT3L in mouse model[J]. Immunopharmacol Immunotoxicol, 40, 1-5. doi: 10.1080/08923973.2017.1405440
-
Garg R, Shrivastava P, Van Drunen Littel-van den Hurk S, 2012: The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development[J]. Expert Rev Vaccines, 11, 1441-1457. doi: 10.1586/erv.12.117
-
Ge Y, Waldemer RJ, Nalluri R, Nuzzi PD, Chen J, 2013: Flt3L is a novel regulator of skeletal myogenesis[J]. J Cell Sci, 126, 3370-3379. doi: 10.1242/jcs.123950
-
Gilboa E, 2007: DC-based cancer vaccines[J]. J Clin Investig, 117, 1195-1203. doi: 10.1172/JCI31205
-
Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B, 1998: Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system[J]. J Virol, 72, 3711-3719.
-
Hu R, Tang Q, Tang J, Fooks AR, 2009: Rabies in China: an update[J]. Vector Borne Zoonotic Dis, 9, 1-12. doi: 10.1089/vbz.2008.0046
-
Kodama S, Hirano T, Noda K, Abe N, Suzuki M, 2010: A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx[J]. Vaccine, 28, 2510-2516. doi: 10.1016/j.vaccine.2010.01.043
-
Kreiter S, Diken M, Selmi A, Diekmann J, Attig S, Husemann Y, Koslowski M, Huber C, Tureci O, Sahin U, 2011: FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines[J]. Cancer Res, 71, 6132-6142. doi: 10.1158/0008-5472.CAN-11-0291
-
Kreiter S, Diken M, Selmi A, Petschenka J, Tureci O, Sahin U, 2016: FLT3 ligand as a molecular adjuvant for naked RNA vaccines[J]. Methods Mol Biol, 1428, 163-175.
-
Lafon M, 2008: Immune evasion, a critical strategy for rabies virus[J]. Dev Biol (Basel), 131, 413-419.
-
Lutz MB, Kukutsch N, Ogilvie AL, Rössner S, Koch F, Romani N, Schuler G, 1999: An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow[J]. J Immunol Methods, 223, 77-92. doi: 10.1016/S0022-1759(98)00204-X
-
Mathers AR, Larregina AT, 2006: Professional antigen-presenting cells of the skin[J]. Immunol Res, 36, 127-136. doi: 10.1385/IR:36:1:127
-
Miao X, Chen Y, Hao K, Zheng M, Chen B, Li K, Wang Y, Zhang W, Zhang Y, Mou X, Jiang S, Wang Z, 2018: CD103(+) cell growth factor Flt3L enhances the efficacy of immune checkpoint blockades in murine glioblastoma model[J]. Oncol Res, 26, 173-182. doi: 10.3727/096504017X14841698396865
-
Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, Foucat E, Dullaers M, Oh S, Sabzghabaei N, Lavecchio EM, Punaro M, Pascual V, Banchereau J, Ueno H, 2011: Human blood CXCR24(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion[J]. Immunity, 34, 108-121. doi: 10.1016/j.immuni.2010.12.012
-
Murphy FA, Bauer SP, 1974: Early street rabies virus infection in striated muscle and later progression to the central nervous system[J]. Intervirology, 3, 256-268. doi: 10.1159/000149762
-
Mwangi DM, Honda Y, Graham SP, Pelle R, Taracha EL, Gachanja J, Nyanjui JK, Bray J, Palmer GH, Brown WC, Mwangi W, 2011: Treatment of cattle with DNA-encoded Flt3L and GM-CSF prior to immunization with Theileria parva candidate vaccine antigens induces CD4 and CD8 T cell IFN-gamma responses but not CTL responses[J]. Vet Immunol Immunopathol, 140, 244-251. doi: 10.1016/j.vetimm.2010.12.013
-
Nurieva RI, Chung Y, Hwang D, Yang XO, Kang HS, Ma L, Wang YH, Watowich SS, Jetten AM, Tian Q, Dong C, 2008: Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages[J]. Immunity, 29, 138-149. doi: 10.1016/j.immuni.2008.05.009
-
Okonko IO, Adedeji OB, Babalola ET, Fajobi EA, Fowotade A, Adewale OG, 2010: Why is there still rabies in the world?—An emerging microbial and global health threat[J]. Glob Vet, 4, 34-50.
-
Pabst R, Luhrmann A, Steinmetz I, Tschernig T, 2003: A single intratracheal dose of the growth factor Fms-like tyrosine kinase receptor-3 ligand induces a rapid differential increase of dendritic cells and lymphocyte subsets in lung tissue and bronchoalveolar lavage, resulting in an increased local antibody production[J]. J Immunol, 171, 325-330. doi: 10.4049/jimmunol.171.1.325
-
Rasalingam P, Rossiter JP, Mebatsion T, Jackson AC, 2005: Comparative pathogenesis of the SAD-L16 strain of rabies virus and a mutant modifying the dynein light chain binding site of the rabies virus phosphoprotein in young mice[J]. Virus Res, 111, 55-60. doi: 10.1016/j.virusres.2005.03.010
-
Schnell MJ, Mebatsion T, Conzelmann KK, 1994: Infectious rabies viruses from cloned cDNA[J]. EMBO J, 13, 4195-4203. doi: 10.1002/j.1460-2075.1994.tb06739.x
-
Scotch M, Odofin L, Rabinowitz P, 2009: Linkages between animal and human health sentinel data[J]. BMC Vet Res, 5, 15-24. doi: 10.1186/1746-6148-5-15
-
Song M, Tang Q, Rayner S, Tao XY, Li H, Guo ZY, Shen XX, Jiao WT, Fang W, Wang J, Liang GD, 2014: Human rabies surveillance and control in China, 2005-2012[J]. BMC Infect Dis, 14, 212-221. doi: 10.1186/1471-2334-14-212
-
Sudarshan, Madhusudana, Mahendra, Rao, Ashwath, Abdul, Meslin, Lobo, Ravikumar, Gangaboraiah, 2007: Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey[J]. Int J Infect Dis, 11, 29-35. doi: 10.1016/j.ijid.2005.10.007
-
Svensson MN, Andersson SE, Erlandsson MC, Jonsson IM, Ekwall AK, Andersson KM, Nilsson A, Bian L, Brisslert M, Bokarewa MI, 2013: Fms-like tyrosine kinase 3 ligand controls formation of regulatory T cells in autoimmune arthritis[J]. PLoS ONE, 8, e54884-. doi: 10.1371/journal.pone.0054884
-
Tian D, Luo Z, Zhou M, Li M, Yu L, Wang C, Yuan J, Li F, Tian B, Sui B, 2015: Critical role of K1685 and K1829 in the large protein of rabies virus in viral pathogenicity and immune evasion[J]. J Virol, 90, 232-244.
-
Waskow C, Liu K, Darrassejèze G, Guermonprez P, Ginhoux F, Merad M, Shengelia T, Yao K, Nussenzweig M, 2008: The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues[J]. Nat Immunol, 9, 676-683. doi: 10.1038/ni.1615
-
Wen Y, Wang H, Wu H, Yang F, Tripp RA, Hogan RJ, Fu ZF, 2011: Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination[J]. J Virol, 85, 1634-1644. doi: 10.1128/JVI.01552-10
-
WHO (2013) WHO expert consultation on rabies. Second report. World Health Organ Tech Rep Ser 982: 1
-
Wu X, Smith TG, Franka R, Wang M, Carson WC, Rupprecht CE, 2014: The feasibility of rabies virus-vectored immunocontraception in a mouse model[J]. Trials Vaccinol, 3, 11-18. doi: 10.1016/j.trivac.2013.11.003
-
Wunner WH, Briggs DJ, 2010: Rabies in the 21 century[J]. PLoS Negl Trop Dis, 4, e591-. doi: 10.1371/journal.pntd.0000591
-
Xu Q, Zhu YF, Wang HC, Gong ZW, Yu YZ, 2016: Enhanced efficacy of DNA vaccination against botulinum neurotoxin serotype A by co-administration of plasmids encoding DC-stimulating Flt3L and MIP-3alpha cytokines[J]. Biologicals, 44, 441-447. doi: 10.1016/j.biologicals.2016.04.008
-
Zhao L, Toriumi H, Kuang Y, Chen HC, Fu ZF, 2009: The roles of chemokines in rabies virus infection: overexpression may not always be beneficial[J]. J Virol, 83, 11808-11818. doi: 10.1128/JVI.01346-09
-
Zhou Q, Wang F, Yang F, Wang Y, Zhang X, Sun S, 2010: Augmented humoral and cellular immune response of hepatitis B virus DNA vaccine by micro-needle vaccination using Flt3L as an adjuvant[J]. Vaccine, 28, 1357-1362. doi: 10.1016/j.vaccine.2009.11.006
-
Zhou M, Zhang G, Ren G, Gnanadurai CW, Li Z, Chai Q, Yang Y, Leyson CM, Wu W, Cui M, Fu ZF, 2013: Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations[J]. PLoS ONE, 8, e63384-. doi: 10.1371/journal.pone.0063384
-
Zhou M, Wang L, Zhou S, Wang Z, Ruan J, Tang L, Jia Z, Cui M, Zhao L, Fu ZF, 2015: Recombinant rabies virus expressing dog GM-CSF is an efficacious oral rabies vaccine for dogs[J]. Oncotarget, 6, 38504-38516.
-
Zurkova K, Hainz P, Krystofova J, Kutinova L, Sanda M, Nemeckova S, 2010: Attenuation of vaccinia virus by the expression of human Flt3 ligand[J]. Virol J, 7, 109-124. doi: 10.1186/1743-422X-7-109